Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with ...

New research shows GLP-1 drugs may be linked to a twofold increase in the risk of wet AMD among people with diabetes.

Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...

The drugs in question, known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), include popular names like semaglutide ... Neovascular Age-Related Macular Degeneration Go to source).

Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular ...

Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...